Clinical Trials Browser

Phase 1 × Interventional × Advanced Unresectable Solid Tumors × Clear all

NCT04894825 2023-11-27

Safety, Tolerability and Pharmacokinetic Profile of M108 Monoclonal Antibody in Patients With Advanced Unresectable Solid Tumors in China

Phase 1 Unknown

Other solid neoplasm

Advanced Unresectable Solid Tumors